Ondine Biomedical Inc. (LON:OBI) Insider Carolyn Cross Buys 200,775 Shares of Stock

Ondine Biomedical Inc. (LON:OBI) insider Carolyn Cross bought 200,775 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were acquired at an average price of GBX 12 ($0.15) per share, for a total transaction of £24,093 ($29,858.72).

Ondine Biomedical Stock Performance

Shares of OBI stock opened at GBX 12.21 ($0.15) on Friday. The company has a current ratio of 0.80, a quick ratio of 8.26 and a debt-to-equity ratio of 1,847.37. Ondine Biomedical Inc. has a 12-month low of GBX 4.50 ($0.06) and a 12-month high of GBX 13.30 ($0.16). The business’s 50 day moving average is GBX 9.16 and its two-hundred day moving average is GBX 7.98. The company has a market capitalization of £33.86 million, a P/E ratio of -407.03 and a beta of 0.10.

Ondine Biomedical Company Profile

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.